Advanced search
Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 26, 2019 - Issue 4
Submit an article Journal homepage
3,967
Views
13
CrossRef citations to date
0
Altmetric
Articles

A comprehensive safety profile of tafamidis in patients with transthyretin amyloid polyneuropathy

Peter HuberPfizer Inc., Collegeville, PA, USA; View further author information
,
Alison FlynnPfizer Inc., Collegeville, PA, USA; Correspondence[email protected]
View further author information
,
Marla B. SultanPfizer Inc., New York, NY, USA; View further author information
,
Huihua LiPfizer Inc., Collegeville, PA, USA; View further author information
,
Denise RillPfizer Inc., Collegeville, PA, USA; View further author information
,
Ben EbedePfizer Inc., Collegeville, PA, USA; View further author information
,
Balarama GundapaneniPfizer Inc., Groton, CT, USAView further author information
&
Jeffrey H. SchwartzPfizer Inc., New York, NY, USA; View further author information
 show all
Pages 203-209 | Received 14 Nov 2018, Accepted 09 Jul 2019, Published online: 27 Jul 2019

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Catarina Falcão de Campos & Isabel Conceição. (2023) Updated Evaluation of the Safety, Efficacy and Tolerability of Tafamidis in the Treatment of Hereditary Transthyretin Amyloid Polyneuropathy. Drug, Healthcare and Patient Safety 15, pages 51-62.
Read now
Arianna Burton, Adam Castaño, Marianna Bruno, Steve Riley, Jennifer Schumacher, Marla B Sultan, Sandi See Tai, Daniel P Judge, Jignesh K Patel & Jeffery W Kelly. (2021) Drug Discovery and Development in Rare Diseases: Taking a Closer Look at the Tafamidis Story. Drug Design, Development and Therapy 15, pages 1225-1243.
Read now
Matthias N. Ungerer, Ernst Hund, Jan C. Purrucker, Laura Huber, Christoph Kimmich, Fabian aus dem Siepen, Selina Hein, Arnt V. Kristen, Katrin Hinderhofer, Jennifer Kollmer, Stefan Schönland, Ute Hegenbart & Markus Weiler. (2021) Real-world outcomes in non-endemic hereditary transthyretin amyloidosis with polyneuropathy: a 20-year German single-referral centre experience. Amyloid 28:2, pages 91-99.
Read now

Articles from other publishers (10)

Deandre King, K. H. Vincent Lau & Michelle C. Kaku. (2023) Treatment Updates for Neuropathy in Hereditary Transthyretin Amyloidosis. Current Treatment Options in Neurology 25:6, pages 137-149.
Crossref
G. Chandrasekhar & R. Rajasekaran. (2023) Theoretical investigations of TTR derived aggregation-prone peptides’ potential to biochemically attenuate the amyloidogenic propensities of V30 M TTR amyloid fibrils. Journal of the Indian Chemical Society 100:2, pages 100892.
Crossref
Fabio Mastrocola, Frank Nunes & Paulo Sgobbi. 2023. Amyloidosis and Fabry Disease. Amyloidosis and Fabry Disease 235 276 .
Amirthalingam Mohankumar, Duraisamy Kalaiselvi, Govindhan Thiruppathi, Sivaramakrishnan Muthusaravanan, Subramaniam Vijayakumar, Rahul Suresh, Shinkichi Tawata & Palanisamy Sundararaj. (2022) Santalol Isomers Inhibit Transthyretin Amyloidogenesis and Associated Pathologies in Caenorhabditis elegans. Frontiers in Pharmacology 13.
Crossref
Laura Obici & Roberta Mussinelli. (2021) Current and Emerging Therapies for Hereditary Transthyretin Amyloidosis: Strides Towards a Brighter Future. Neurotherapeutics 18:4, pages 2286-2302.
Crossref
Muneeb Ullah, Abdul Wahab, Sumbul Saeed, Shahid Ullah Khan, Haider Ali, Shah Humayun, Banzeer Ahsan Abbasi, Shah Saud, Khalid Naveed, Sher Aslam Khan & Shah Fahad. (2021) Coronavirus and its terrifying inning around the globe: The pharmaceutical cares at the main frontline. Chemosphere 275, pages 129968.
Crossref
Meissane Benbrahim, Kelsey Norman, Vaishali Sanchorawala, Omar K Siddiqi & David Hughes. (2021) A review of novel agents and clinical considerations in patients with ATTR cardiac amyloidosis. Journal of Cardiovascular Pharmacology Publish Ahead of Print.
Crossref
Evan T. Powers & Jeffery W. Kelly. 2021. Neurotherapeutics in the Era of Translational Medicine. Neurotherapeutics in the Era of Translational Medicine 65 103 .
Laura Obici & David Adams. (2020) Acquired and inherited amyloidosis: Knowledge driving patients' care. Journal of the Peripheral Nervous System 25:2, pages 85-101.
Crossref
Jonathan Park, Ugochukwu Egolum, Shanea Parker, Ebony Andrews, David Ombengi & Hua Ling. (2019) Tafamidis: A First-in-Class Transthyretin Stabilizer for Transthyretin Amyloid Cardiomyopathy. Annals of Pharmacotherapy 54:5, pages 470-477.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.